Thao K. Adams, PharmD, BCOP

New and emerging treatment modalities for advanced nonmelanoma skin cancer provide hope for this patient subset.

Several notable trials in colorectal cancer suggest a shift in treatment management, especially in the length of treatment with immunotherapies.

There are still a lot of things that are ongoing, and the myeloma field is evolving with new treatments, according to Mark Bustoros, MBBCh.

Nanotechnology advances in oncology have applications in diagnosis, biomarker screening, and most notably, treatment.